From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding the ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...

A pharma industry group asked the FDA to "take action" against a "dangerous" ad Hims & Hers plans to run during the Super ...

Two senators wrote to the FDA Friday about the Hims Super Bowl ad, which they said misleads patients about compounded weight ...

This is common. Those of us in research routinely store patient samples — blood, fluids, tissue, scrapings, and other ...

A ruling may come this month on UnitedHealth's motion to dismiss a lawsuit stemming from STAT reporting on the firm's use of ...

The Howard Hughes Medical Institute abruptly ended a $60 million program to improve the retention of diverse college students ...

Why are CRISPR companies not OK? Will Robert F. Kennedy Jr. keep his promises if he's confirmed to lead the Department of ...

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR ...